Baxter gains on 2026 profit forecast raise, Q3 results beat

By Reuters News

** Shares of medical equipment maker Baxter International BAX.N rise 4.3% to $26.55 premarket

** Company raises annual adjusted profit expectations to a range of $2.05 to $2.15 per share, from $1.95 to $2.15 earlier

** BAX reports Q3 adj. profit of 58 cents per share vs analysts' est. of 52 cents - data compiled by LSEG

** Q3 revenue at $2.98 billion vs est. of $2.91 billion

** Expects annual revenue to grow 4% to 5%, compared with 3% to 4% increase forecast earlier

** As of last close, BAX shares up 33.2% YTD

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk